Showing results (131-140 of 212) with videos related to
Sort By:
Pageof 22
Toxicology|January 1, 1992
Placental aryl hydrocarbon hydroxylase activity and placental calcificationsG Huel, F Girard, C Nessmann, et al.Neurotoxicology|January 1, 1996
Color vision loss among styrene-exposed workers neurotoxicological threshold assessmentD Campagna, F Gobba, D Mergler, et al.Neuroepidemiology|July 11, 2006
The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosisC Binquet, C Quantin, G Le Teuff, et al.Medinfo. MEDINFO|January 1, 1995
Structural and conjunctural compensation method for hospital budgetary allocation on the basis of DRGsC Quantin, C Mathy, T Moreau, et al.European Journal of Biochemistry|May 19, 2001
Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3S Réhault, P Monget, S Mazerbourg, et al.Revue D'Epidemiologie Et De Sante Publique|June 28, 2001
A method for shortening instruments using the Rasch model. Validation on a hand functional measureC Luquet, N Chau, F Guillemin, et al.Epilepsia|August 13, 1998
Epilepsy in patients with multiple sclerosis: radiological-clinical correlationsT Moreau, D Sochurkova, M Lemesle, et al.Journal of Exposure Analysis and Environmental Epidemiology|January 1, 1993
Aryl hydrocarbon hydroxylase activity in human placenta and threatened preterm deliveryG Huel, J Godin, N Frery, et al.Biochimica Et Biophysica Acta|June 19, 2001
Purification and characterization of active recombinant rat kallikrein rK9M Zani, M Brillard-Bourdet, C Lazure, et al.Archives of Biochemistry and Biophysics|November 1, 1993
A new, sensitive fluorogenic substrate for papain based on the sequence of the cystatin inhibitory siteF Gauthier, T Moreau, G Lalmanach, et al.Pageof 22